Global Drug Delivery Market Forecast 2022-2030
KEY FINDINGS
The global drug delivery market is projected to record a CAGR of 6.84% during the estimated years of 2022 to 2030. The market growth is mainly reinforced by the increasing usage of biological drugs, technical advancements in drug delivery techniques, the increasing incidence of chronic conditions and prevailing aging population, as well as the rising need for effective drug delivery mechanisms.
MARKET INSIGHTS
Drug delivery entails the process of administering a pharmaceutical compound in order to provide therapy for various conditions. These drug delivery technologies alter the profile of drug releases, such as distribution, absorption, and elimination for the improvement of product safety and efficacy. It also considers patient convenience as well as compliance with the drug. The common routes of administration include oral, enteral, inhalation, parenteral, topical, and transdermal patches routes.
Technological advancements in the avenue of drug delivery technology are one of the leading factors propelling the global market’s growth. In addition, the introduction of novel delivery platforms is anticipated to introduce solutions that optimize a drug’s therapeutic value, thus finding a relatively improved approach to get a drug into the patient’s body consistently and safely. As a result, this aspect leads to improved compliance and outcomes.
REGIONAL INSIGHTS
The global drug delivery market growth assessment includes the analysis of North America, Europe, Asia-Pacific, and Rest of World. The Asia-Pacific is set to grow with the highest CAGR. The regional market’s growth is attributed to the increasing healthcare awareness, the surge in disposable income and government expenditure, and the rise in healthcare spending. Furthermore, domestic enterprises in the Asia-Pacific are fundamentally engaged in the manufacture of low-costing smart syringes for international as well as local usage.
COMPETITIVE INSIGHTS
The global drug delivery market is competitive, with top players involved in continuous partnership alliances and product development to aid market penetration. Moreover, the increasing number of dealers and distributors is set to elevate industry rivalry over the upcoming years.
Some of the key companies operating in the market are Antares Pharma Inc, Baxter International Inc, Johnson & Johnson, etc.
Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation cater to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments
- 1. Research Scope & Methodology
- 1.1. Study Objectives
- 1.2. Scope Of Study
- 1.3. Methodology
- 1.4. Assumptions & Limitations
- 2. Executive Summary
- 2.1. Market Size & Estimates
- 2.2. Market Overview
- 3. Market Dynamics
- 3.1. Key Drivers
- 3.1.1. Technological Advancements In Drug Delivery Techniques
- 3.1.2. Increasing Usage Of Biological Drugs
- 3.1.3. Growing Demand For Effective Drug Delivery Mechanisms
- 3.1.4. Rising Incidence Of Chronic Diseases And Prevailing Aging Population
- 3.2. Key Restraints
- 3.2.1. Increasing Drug Recalls And Drug Failures
- 3.2.2. Government Regulations Delaying Processes
- 3.2.3. Side Effects And Risks Associated With The Drugs
- 4. Key Analytics
- 4.1. Impact Of Covid-19 On Drug Delivery Market
- 4.2. Key Market Trends
- 4.3. Porter’s Five Forces Analysis
- 4.3.1. Buyers Power
- 4.3.2. Suppliers Power
- 4.3.3. Substitution
- 4.3.4. New Entrants
- 4.3.5. Industry Rivalry
- 4.4. Key Buying Criteria
- 4.5. Regulatory Framework
- 4.6. Opportunity Matrix
- 4.7. Vendor Landscape
- 5. Market By Route Of Administration
- 5.1. Oral Drug Delivery
- 5.1.1.1. Solid Oral Drugs
- 5.1.1.1.1. Tablets
- 5.1.1.1.2. Capsules
- 5.1.1.1.3. Powders
- 5.1.1.1.4. Pills
- 5.1.1.2. Liquid Oral Drugs
- 5.1.1.2.1. Solutions
- 5.1.1.2.2. Syrups
- 5.1.1.3. Semi-solid Oral Drugs
- 5.1.1.3.1. Oral Emulsions
- 5.1.1.3.2. Gels
- 5.1.1.3.3. Elixirs
- 5.2. Injectable Drug Delivery
- 5.2.1.1. Formulations
- 5.2.1.1.1. Conventional Drug Delivery Injections
- 5.2.1.1.2. Long Acting Injectable
- 5.2.1.1.3. Novel Drug Delivery Formulations
- 5.2.1.2. Devices
- 5.2.1.2.1. Conventional Injection Devices
- 5.2.1.2.1.1. Conventional Injection Devices By Material
- 5.2.1.2.1.1.1. Plastic
- 5.2.1.2.1.1.2. Glass
- 5.2.1.2.1.2. Conventional Injection Devices By Product
- 5.2.1.2.1.2.1. Fillable Syringes
- 5.2.1.2.1.2.2. Prefilled Syringes
- 5.2.1.2.1.3. Conventional Injection Devices By Usability
- 5.2.1.2.1.3.1. Disposable Syringes
- 5.2.1.2.1.3.2. Reusable Syringes
- 5.2.1.2.2. Self-injection Devices
- 5.2.1.2.2.1. Needle-free Injectors
- 5.2.1.2.2.2. Pen Injectors
- 5.2.1.2.2.3. Auto-injector
- 5.2.1.2.2.4. Wearable Injectors
- 5.2.1.2.3. Other Injector Devices
- 5.3.1.1. Devices
- 5.3.1.1.1. Metered Dose Inhalers (Mdis)
- 5.3.1.1.2. Nebulizers
- 5.3.1.1.2.1. Jet Nebulizers
- 5.3.1.1.2.2. Ultrasonic Nebulizers Delivery
- 5.3.1.1.2.3. Soft Mist Nebulizers
- 5.3.1.1.3. Dry Powder System
- 5.3.1.2. Formulations
- 5.4.1.1. Formulations
- 5.4.1.1.1. Semi-solid Topical Drug Delivery
- 5.4.1.1.1.1. Creams
- 5.4.1.1.1.2. Ointments
- 5.4.1.1.1.3. Lotions
- 5.4.1.1.1.4. Gels
- 5.4.1.1.1.5. Pastes
- 5.4.1.1.2. Liquid Topical Drug Delivery
- 5.4.1.1.2.1. Solutions
- 5.4.1.1.2.2. Suspensions
- 5.4.1.1.3. Solid Topical Drug Delivery
- 5.4.1.1.3.1. Powders
- 5.4.1.1.3.2. Suppositories
- 5.4.1.2. Devices
- 5.4.1.2.1. Transdermal Patches
- 5.4.1.2.2. Transdermal Gels
- 5.5.1. Nasal Sprays
- 5.5.2. Nasal Drops
- 5.5.3. Nasal Gels
- 5.5.4. Nasal Powders
- 5.6.1. Formulations
- 5.6.1.1. Liquid Formulation
- 5.6.1.1.1. Eye Drops
- 5.6.1.1.2. Liquid Sprays
- 5.6.1.2. Semi-solid Formulation
- 5.6.1.2.1. Eye Ointments
- 5.6.1.2.2. Gels
- 5.6.2. Ocular Devices
- 5.6.2.1. Drug-coated Contact Lenses
- 5.6.2.2. Ocular Insert
- 5.7.1. Oral Transmucosal Drug Delivery
- 5.7.1.1. Buccal Drug Delivery
- 5.7.1.2. Sublingual Drug Delivery
- 5.7.2. Other Transmucosal Drug Delivery
- 5.7.2.1. Rectal Transmucosal Drug Delivery
- 5.7.2.2. Vaginal Transmucosal Drug Delivery
- 5.8.1. Active Implantable Drug Delivery
- 5.8.2. Passive Implantable Drug Delivery
- 7.1.1. Market Size & Estimates
- 7.1.2. Key Growth Enablers
- 7.1.3. Key Challenges
- 7.1.4. Key Players
- 7.1.5. Country Analysis
- 7.1.5.1. United States
- 7.1.5.2. Canada
- 7.2.1. Market Size & Estimates
- 7.2.2. Key Growth Enablers
- 7.2.3. Key Challenges
- 7.2.4. Key Players
- 7.2.5. Country Analysis
- 7.2.5.1. Germany
- 7.2.5.2. France
- 7.2.5.3. United Kingdom
- 7.2.5.4. Italy
- 7.2.5.5. Spain
- 7.2.5.6. Russia
- 7.2.5.7. Poland
- 7.2.5.8. Belgium
- 7.2.5.9. Rest Of Europe
- 7.3.1. Market Size & Estimates
- 7.3.2. Key Growth Enablers
- 7.3.3. Key Challenges
- 7.3.4. Key Players
- 7.3.5. Country Analysis
- 7.3.5.1. China
- 7.3.5.2. Japan
- 7.3.5.3. India
- 7.3.5.4. Australia & New Zealand
- 7.3.5.5. South Korea
- 7.3.5.6. Indonesia
- 7.3.5.7. Thailand
- 7.3.5.8. Vietnam
- 7.3.5.9. Rest Of Asia-pacific
- 7.4.1. Market Size & Estimates
- 7.4.2. Key Growth Enablers
- 7.4.3. Key Challenges
- 7.4.4. Key Players
- 7.4.5. Regional Analysis
- 7.4.5.1. Latin America
- 7.4.5.2. Middle East & Africa
- 8.1.1. Mergers & Acquisitions
- 8.1.2. Product Launches & Developments
- 8.1.3. Partnerships & Agreements
- 8.1.4. Business Expansions, Announcements, And Divestitures
- 8.2.1. Alkermes Plc
- 8.2.2. Antares Pharma Inc
- 8.2.3. Bausch Health Companies Inc (Formerly Valeant Pharmaceuticals)
- 8.2.4. Baxter International Inc
- 8.2.5. Bayer Ag
- 8.2.6. Becton, Dickinson And Company (Bd)
- 8.2.7. Boehringer Ingelheim International Gmbh
- 8.2.8. Boston Scientific Corporation
- 8.2.9. Generex Biotechnology Corporation
- 8.2.10. Glaxosmithkline Plc
- 8.2.11. Johnson & Johnson
- 8.2.12. Kindeva Drug Delivery (Formerly 3m Drug Delivery Systems)
- 8.2.13. Novartis Ag
- 8.2.14. Novo Nordisk A/S
- 8.2.15. Terumo Medical Corporation (Microvention Inc)
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook